Incidence and predictors for cardiovascular events in patients with psoriatic arthritis

被引:85
|
作者
Eder, Lihi [1 ]
Wu, Ying [2 ]
Chandran, Vinod [1 ]
Cook, Richard [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Psoriatic Arthritis; Epidemiology; Atherosclerosis; Cardiovascular Disease; ATHEROSCLEROSIS RISK-FACTORS; POPULATION-BASED COHORT; RHEUMATOID-ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; FRAMINGHAM RISK; DISEASE; INFLAMMATION; METAANALYSIS; PREVALENCE; INDIVIDUALS;
D O I
10.1136/annrheumdis-2015-207980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the incidence and risk factors of cardiovascular events in patients with psoriatic arthritis (PsA). Methods A cohort analysis was conducted involving patients recruited and followed over the period from 1978 to 2013 in a large PsA clinic. The participants were assessed at 6 to 12-month intervals according to a standard protocol. The collected information included demographics, lifestyle habits, medical history, medications use and PsA-related outcomes. The primary outcome was a composite major cardiovascular end point comprising myocardial infarction, ischaemic stroke, revascularisation or cardiovascular death. The association between the features of disease activity and the occurrence of cardiovascular events was assessed using Cox proportional hazard models. Results A total of 1091 patients with PsA were analysed. During the follow-up period, 104 cardiovascular events occurred. A considerable proportion of patients developed a cardiovascular event (19.8% of the patients by the age of 70 years and 30.1% of patient by the age of 80 years). No trend in the risk of developing cardiovascular events was observed over the decades from 1978 to 2013 (p=0.73). In multivariate analysis, the following variables were independent predictors of major cardiovascular events: hypertension (relative risk (RR) 1.81, p=0.015), diabetes (RR 2.72, p<0.001) and the number of dactylitic digits (RR 1.20, p<0.001). Sedimentation rate was a significant predictor only among women (RR 1.83, p=0.02). Conclusion A significant proportion of patients with PsA develop cardiovascular events during the course of their disease. Increased cardiovascular risk is associated with a combination of traditional cardiovascular risk factors and disease activity.
引用
收藏
页码:1680 / 1686
页数:7
相关论文
共 50 条
  • [41] Cardiovascular risk in psoriatic arthritis, a narrative review
    Verhoeven, Frank
    Prati, Clement
    Demougeot, Celine
    Wendling, Daniel
    JOINT BONE SPINE, 2020, 87 (05) : 413 - 418
  • [42] Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis
    Kennedy, M.
    Papneja, A.
    Thavaneswaran, A.
    Chandran, V.
    Gladman, D. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (03) : 342 - 348
  • [43] Predictors of response to TNF blockers in patients with polyarticular psoriatic arthritis
    Carvalho, P. D.
    Duarte, C.
    Vieira-Sousa, E.
    Cunha-Miranda, L.
    Avila-Ribeiro, P.
    Santos, H.
    Bernardes, M.
    Santos, M. J.
    Cerqueira, M.
    Mateus, M.
    Nero, P.
    Agueda, A.
    da Silva, J. A.
    Machado, P.
    ACTA REUMATOLOGICA PORTUGUESA, 2017, 42 (01): : 55 - 65
  • [44] The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study
    Eder, Lihi
    Chandran, Vinod
    Cook, Richard
    Gladman, Dafna D.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (03) : 286 - 291
  • [45] Cardiovascular risk factors in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis: a cross-sectional survey of patients in Western Sweden
    Landgren, Anton Jonatan
    Dehlin, Mats
    Jacobsson, Lennart
    Bergsten, Ulrika
    Klingberg, Eva
    RMD OPEN, 2021, 7 (02):
  • [46] Cardiovascular risk reclassification according to six cardiovascular risk algorithms and carotid ultrasound in psoriatic arthritis patients
    Galarza-Delgado, Dionicio A.
    Azpiri-Lopez, Jose R.
    Colunga-Pedraza, Iris J.
    Guajardo-Jauregui, Natalia
    Rodriguez-Romero, Alejandra B.
    Lugo-Perez, Salvador
    Cardenas-de la Garza, Jesus A.
    Arvizu-Rivera, Rosa, I
    Flores-Alvarado, Diana E.
    Ilizaliturri-Guerra, Octavio
    Garcia-Arellano, Gisela
    Garza-Acosta, Andrea C.
    CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1413 - 1420
  • [47] Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database
    Di Minno, Matteo Nicola Dario
    Iervolino, Salvatore
    Zincarelli, Carmela
    Lupoli, Roberta
    Ambrosino, Pasquale
    Pizzicato, Paolo
    Di Minno, Alessandro
    Pappone, Nicola
    Peluso, Rosario
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1905 - 1913
  • [48] On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-TrOndelag Health Study
    Gulati, Agnete Malm
    Semb, Anne Grete
    Rollefstad, Silvia
    Romundstad, Pal R.
    Kavanaugh, Arthur
    Gulati, Sasha
    Haugeberg, Glenn
    Hoff, Mari
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 819 - 824
  • [49] Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
    Tobin, Anne-Marie
    Veale, Douglas J.
    Fitzgerald, Oliver
    Rogers, Sarah
    Collins, Paul
    O'Shea, Donal
    Kirby, Brian
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1386 - 1394
  • [50] The Incidence and Predictors of Infection in Psoriasis and Psoriatic Arthritis: Results from Longitudinal Observational Cohorts
    Haddad, Amir
    Li, Suzanne
    Thavaneswaran, Arane
    Cook, Richard J.
    Chandran, Vinod
    Gladman, Dafna D.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 362 - 366